BioInvest ApS: Financial statements 2021
CVR: 41998288
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
BioInvest ApS (CVR 41998288) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 0 and a net result of DKK 284,250,983 compared with DKK 81,549,502 the year before. Equity in the 2021 report amounted to DKK 387,551,053. The solvency ratio was 99.8%.
- Gross Profit
- DKK 0
- Profit/Loss
- DKK 284,250,983
- Equity
- DKK 387,551,053
- Total Assets
- DKK 388,267,576
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 0 | 284.3 mio. | 387.6 mio. | 0 |
| 2020 | - | -20 t. | 81.5 mio. | 103.3 mio. | 0 |
Official annual report
Find more companies like BioInvest ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
BioInvest ApS has published its annual report for 2020. Gross profit came to DKK -20,000, and the net result was DKK 81,549,502.
About BioInvest ApS
BioInvest ApS was a Danish company of the type Anpartsselskab based in Holte, founded in 2020. The company has been dissolved on 9 November 2023. The company was registered under the industry Ikke-finansielle holdingselskaber. According to the 2022 annual report, the company had an average of 0 employees. In 2022, the company reported a gross profit of DKK -12,500 and a net result of DKK -183,766,349 compared with DKK 284,250,983 the year before. Equity in the 2022 report amounted to DKK 203,784,704.